John A. Kosteva

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Stephen Bagley, Shawn Kothari, Charu Aggarwal et al. · Lung Cancer · 2017 · 529 citations

Medicine, Immunology, Oncology +16

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Jeffrey C. Thompson, Stephanie S. Yee, Andrea B. Troxel et al. · Clinical Cancer Research · 2016 · 328 citations

Medicine, Molecular Biology, Oncology +17

Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer

Charu Aggarwal, Melina E. Marmarelis, Wei‐Ting Hwang et al. · JCO Precision Oncology · 2023 · 44 citations

Medicine, Biostatistics, Oncology +15

Immune thrombocytopenia exacerbated by nivolumab in a patient with non-small-cell lung cancer

Stephen Bagley, John A. Kosteva, Tracey L. Evans et al. · Cancer Treatment Communications · 2016 · 30 citations

Medicine, Immunology, Oncology +14

Association of comprehensive molecular genotyping and overall survival in patients with advanced non-squamous non-small cell lung cancer.

Charu Aggarwal, Melina E. Marmarelis, Wei‐Ting Hwang et al. · Journal of Clinical Oncology · 2022 · 19 citations

Medicine, Molecular Genetics, Oncology +17